Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Fibrosis × alpha-Tocopherol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Radiation-induced Injuries in Patients With Rectal Cancer 1 Radiation Injuries 1 Precancerous Conditions 1 Neoplasms, Second Primary 1 Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Fibrosis 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adenomatous Polyps 1

Interventions

esmolol 1 epigallocatechin gallate 1 contrast agent BR1 1 alpha-Tocopherol 1 Viusid 1 Sonazoid 1 Sodium Chloride 1 Simvastatin 1 Pentoxifylline 1 Iodides 1 Everolimus 1 Dietary Supplements 1 Catechin 1 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02898376 2018-08-08

FIBROTHERME

Institut de Cancérologie de Lorraine

Phase 3 Unknown

Breast Neoplasms, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡